Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Temozolomide
×
Tumor-Agnostic
×
Clear all
Filters
3
NCT03899155
2026-04-01
Pan Tumor Rollover Study
Bristol-Myers Squibb
Phase 2
Recruiting
1,500 enrolled
NCT05999994
2026-03-27
CAMPFIRE
Eli Lilly and Company
Phase 2
Recruiting
105 enrolled